Alliancebernstein L.P. Eq Rx, Inc. Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$1.61 - $1.96 $125,821 - $153,174	78,150 Added 33.71%	309,950 $576,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $174,659 - $468,600	85,200 Added 58.12%	231,800 $570,000
Q3 2022 Nov 15, 2022	SELL	$0.94 - $5.99 $448,856 - $2.86 Million	-477,507 Reduced 76.51%	146,600 $726,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $2 Million - $3.55 Million	624,107 New	624,107 $2.93 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.